Free Subscription

  • Access daily briefings and unlimited news articles

Premium

From $39.95 per year
  • Quarterly magazine and digital
  • Indepth executive interviews
  • Unlimited news and insights
  • Expert opinion and analysis
User Image

Maggie Fick

From the author

Serena Williams poses for an ad campaign by U.S. telehealth firm Ro for GLP-1 weight-loss medicines manufactured by drugmakers Novo Nordisk.
Pharmaceuticals

Pills, TikTok and apps: The consumer-driven future of weight loss jabs​

GLP-1s are shifting from clinics to smartphones – with huge implications for retailers.
Maggie Fick
Jan 9, 2026